Oncology Clinical Trials in Ann Arbor, MI
As of August 2026, 176 paid clinical trials are recruiting for Oncology in Ann Arbor, Michigan. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Ann Arbor
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
178 clinical trials for Oncology
·Clear filters·A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study of PHST001 in Advanced Solid Tumors
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Top Research Study Locations in Ann Arbor
Researchers run research studies in Ann Arbor, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan | Healthy, Heart Failure, Acute Kidney Injury | 389 |
| University of Michigan Rogel Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | 80 |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 65 |
| C S Mott Children's Hospital | B Acute Lymphoblastic Leukemia, Neuroblastoma, Acute Myeloid Leukemia | 29 |
| University of Michigan Comprehensive Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Carcinoma | 27 |
| University of Michigan Health System | Chronic Kidney Disease, ADA SCID, Adolescent Congenital Heart Disease | 23 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Prostate Cancer, Adult Growth Hormone Deficiency, Alcohol Use Disorder | 23 |
| C.S. Mott Children's Hospital | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Anaplastic Astrocytoma | 18 |
| University of Michigan Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 14 |
| University of Michigan School of Dentistry | Gum Disease, Healing Wound, Dental Diseases | 9 |
| University of Michigan Health | Aortic Stenosis, Breast Reconstruction, Colorectal Adenoma | 8 |
| University of Michigan Hospitals | Propionic Acidemia, Adenoid Cystic Carcinoma, Chromophobe Renal Cell Carcinoma | 8 |
| University of Michigan Medical Center | Liver Transplant, Cutaneous Melanoma, Stage II, Glomerulosclerosis, Focal Segmental | 8 |
| Michigan Medicine | Sleep Apnea, Obstructive, Aging, Alzheimer Disease | 6 |
| University of Michigan Kellogg Eye Center | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 6 |
| University of Michigan, Michigan Medicine | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 6 |
| CS Mott Children's Hospital | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Advanced Solid Tumor | 5 |
| Trinity Health IHA - Obstetrics and Gynecology West Arbor | Ampulla of Vater Carcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 5 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Multiple Myeloma, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | 4 |
| Saint Joseph Mercy Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 4 |
| The University of Michigan | Down Syndrome, Hypertonia, Muscle, Nasal Airway Obstruction | 4 |
| VA Ann Arbor Healthcare System | Cardiovascular Diseases, Castrate-sensitive, Castrate-sensitive Prostate Cancer | 4 |
| University of Michigan Health System - Ann Arbor | Asthma, Plasma Cell Myeloma Refractory, Autoimmune Haemolytic Anaemia | 4 |
| C.S Mott Children's Hospital | Neuroblastoma | 3 |
| Michigan Med University of Michigan | ANCA Associated Vasculitis (AAV), Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
Active & Upcoming Studies in Ann Arbor (2026)
Recruiting trials in Ann Arbor grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (280 active studies)
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · Phase 1 · University of Michigan Rogel Cancer Center
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · University of Michigan Rogel Cancer Center
Neurology & pain (76 active studies)
- This Study Evaluates the Use of a Data-driven Lower Limb Exoskeleton Controller for Stroke Rehabilitation. · University of Michigan
- Telerehabilitation for Post-Stroke Hand Function · University of Michigan
Cardiovascular (61 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Mobile Health Intervention to Increase Activity in Heart Failure Study · University of Michigan
Diabetes & metabolic (26 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD) · University of Michigan
Mental health & behavior (23 active studies)
- Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression · University of Michigan
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Pediatric (15 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Eye & vision (10 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
HIV / STI (5 active studies)
- A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH) · University of Michigan
- National Liver Cancer Screening Trial · Phase 4 · University of Texas Southwestern Medical Center
Vaccines (4 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- KIDney Injury in Times of COVID-19 (KIDCOV) · University of California, San Francisco
Common conditions studied in Ann Arbor
- Heart Failure (10 active studies)
- Malignant Solid Neoplasm (10 active studies)
- Obesity (10 active studies)
- Stroke (10 active studies)
- Advanced Solid Tumor (9 active studies)
- Prostate Cancer (9 active studies)
Leading research sponsors in Ann Arbor
- University of Michigan
- University of Michigan Rogel Cancer Center
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ann Arbor?
There are approximately 970 recruiting clinical trials in Ann Arbor, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ann Arbor pay participants?
Most recruiting trials in Ann Arbor compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ann Arbor?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ann Arbor?
The most common conditions under active study in Ann Arbor include Heart Failure (10), Malignant Solid Neoplasm (10), Obesity (10), Stroke (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ann Arbor?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ann Arbor on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ann Arbor?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ann Arbor?
Recruiting research sites in Ann Arbor include University of Michigan, University of Michigan Rogel Cancer Center, Trinity Health Saint Joseph Mercy Hospital Ann Arbor, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ann Arbor right now?
The largest active categories in Ann Arbor are Cancer & tumors (280), Neurology & pain (76), Cardiovascular (61). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.